US 12215169
Anti-complement C1s antibodies and uses thereof
granted A61KA61K2039/54A61K2039/545
Quick answer
US patent 12215169 (Anti-complement C1s antibodies and uses thereof) held by Bioverativ USA Inc. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bioverativ USA Inc.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/54, A61K2039/545, A61P, A61P13/12